Search

for
Search:

Learn

0 / 0 results

— no results

Research

4 / 4 results

Drug Interactions Between Common Dermatological Medications and the Oral Anti-Covid-19 Agents Nirmatrelvir-Ritonavir and Molnupiravir

research Drug Interactions Between Common Dermatological Medications and the Oral Anti-Covid-19 Agents Nirmatrelvir-Ritonavir and Molnupiravir

5 citations, December 2022 in “Annals Academy of Medicine Singapore”

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

research Does Nirmatrelvir/Ritonavir Influence the Immune Response Against SARS-CoV-2 Independently From Rebound?

October 2023 in “Microorganisms”

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

research Grade Guidance 36: Updates to GRADE's Approach to Addressing Inconsistency

8 citations, March 2023 in “Journal of Clinical Epidemiology”

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

research The Role of Neurorehabilitation in Post-COVID-19 Syndrome

May 2023 in “Clinical and translational neuroscience”

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Community Join

0 / 0 results

— no results